| Compassus Home Health - Butte | |
| 3745 Harrison Ave Ste G, Butte, Montana 59701 | |
| (406) 494-0039 | |
| Name | Compassus Home Health - Butte |
|---|---|
| Location | 3745 Harrison Ave Ste G, Butte, Montana |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 277058 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 59701, 59711, 59748 |
| NPI Number | 1093780702 |
| Organization Name | BETA FACTOR HOME CARE INC |
| Address | 3212 Busch St, Butte, MT 59701 |
| Phone Number | 406-494-0039 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
| NPI Number | 1982963930 |
| Organization Name | BETA FACTOR HOME CARE, LLC |
| Doing Business As | COMPASSUS HOME HEALTH BUTTE MT |
| Address | 19 Discovery Dr, Butte, MT 59701 |
| Phone Number | 406-494-0039 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
| Quality Rating: |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 87.5 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99 | 99.6 |
| How often the home health team checked patients for depression | 98.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 85.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.3 | 96.4 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 69.6 | 79.6 |
| How often patients got better at getting in and out of bed | 84.6 | 81.1 |
| How often patients got better at bathing | 78 | 82.3 |
| How often patients’ breathing improved | 86.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 54.5 | 75 |
| How often home health patients had to be admitted to the hospital | 16.3 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 92.3 | 94 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
The patient survey data of Compassus Home Health - Butte is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 88 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 79 | 78 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.
AbleNet announces a new partnership with the British company Possum Limited, to market and sell their product line in Environmental Control Units (ECU) to the North American market. Possum Limited is an independent, privately owned British company, which develops, manufactures, supplies, installs and supports electronic assistive technology products and systems. AbleNet will begin marketing the Possum products in January 2010.
› Verified 6 days ago
Compassus Home Health - Butte Location: 3745 Harrison Ave Ste G, Butte, Montana 59701 Ratings: Phone: (406) 494-0039 |